Healthcare Services

Deep Learning In Drug Discovery And Diagnostics Market Expected to Record Steady Growth and Approach $36.95 Billion by 2030

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Deep Learning In Drug Discovery And Diagnostics Market By 2030 Starting From Its 2026 Size?

The deep learning in drug discovery and diagnostics market has experienced an exponential increase in its size during recent years. This market is forecast to expand from $10.58 billion in 2025 to $13.61 billion by 2026, registering a compound annual growth rate (CAGR) of 28.7%. Factors contributing to its historical growth encompass the increasing availability of large biomedical datasets, rising computational power for model training, the expansion of AI adoption in pharmaceutical R&D, a growing demand for faster drug discovery cycles, and the early success of deep learning diagnostic models.

The deep learning in drug discovery and diagnostics market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $36.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 28.4%. This growth during the forecast period is primarily driven by factors such as increasing investments in AI-powered healthcare solutions, a growing demand for precision medicine, the wider integration of AI across clinical workflows, the expanding utilization of real-world evidence data, and greater regulatory approval for AI-assisted diagnostics. Prominent trends expected in this period involve the rising implementation of deep neural networks in drug screening, increased application of AI-driven predictive modeling in diagnostics, an expanding integration of multi-omics data analysis, the development of automated clinical decision support systems, and a heightened emphasis on personalized medicine platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19394&type=smp

What Drivers Are Shaping The Future Growth Of The Deep Learning In Drug Discovery And Diagnostics Market?

The expanding need for tailored medicine is anticipated to fuel the progression of the deep learning in drug discovery and diagnostics market. This approach involves customizing medical care and interventions based on a person’s specific genetic makeup, environment, and lifestyle to boost effectiveness and lessen adverse reactions. The increasing call for personalized medicine stems from breakthroughs in genomics and data analytics, enabling more precise and successful therapies suited to individual patient profiles. Within the deep learning in drug discovery and diagnostics domain, its application strengthens personalized medicine by scrutinizing intricate biological information to pinpoint distinct biomarkers and forecast patient responses to treatments with greater precision. For example, in February 2024, as reported by the Personalized Medicine Coalition, a US-based non-profit organization, the FDA sanctioned 16 novel personalized therapies for patients with rare diseases in 2023, which is an increase from six in 2022. Consequently, the rising demand for personalized medicine propels the deep learning in drug discovery and diagnostics market.

Which Segment Categories Define The Deep Learning In Drug Discovery And Diagnostics Market?

The deep learning in drug discovery and diagnostics market covered in this report is segmented –

1) By Type: Drug Discovery, Diagnostics, Forensic Interventions, Other Types

2) By Drug Type: Small Molecule Drugs, Biologics Drugs

3) By End Use Industry: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Healthcare Information Technology (IT)

Subsegments:

1) By Drug Discovery: Target Identification, Drug Screening, Lead Optimization, Predictive Modeling

2) By Diagnostics: Medical Imaging Analysis, Genomic Data Interpretation, Disease Detection Algorithms, Personalized Medicine

3) By Forensic Interventions: Digital Pathology, Forensic DNA Analysis, Toxicology Screening, Crime Scene Reconstruction

4) By Other Types: Biomarker Discovery, Predictive Analytics in Healthcare, Patient Data Management Systems

What Key Trends Are Influencing The Development Of The Deep Learning In Drug Discovery And Diagnostics Market?

Major companies within the deep learning in drug discovery and diagnostics market are adopting advanced technologies such as generative artificial intelligence (AI) and machine-learning (ML)–driven automation platforms. This strategic incorporation aims to boost efficiency, reduce research and development (R&D) expenditures, and accelerate the early stages of therapeutic discovery. Generative AI and ML-driven automation platforms are computational systems designed to learn from chemical and biological data, enabling them to design new drug candidates virtually (in silico), forecast molecular behavior, and automatically synthesize and test compounds using robotic systems, thereby lessening reliance on traditional high-throughput screening methods. For instance, in July 2024, Exscientia, a UK-based AI-driven drug-design company, unveiled its AWS-powered AI/ML platform. This platform integrates a “DesignStudio” for AI-based molecule generation with an “AutomationStudio” for robotic lab synthesis and testing. Operating in a closed “design–make–test–learn” loop, the platform continuously refines its AI models with experimental data, significantly speeding up the discovery process, improving scalability, and facilitating the more precise and cost-effective development of novel therapeutics.

Who Are The Top Companies Competing In The Deep Learning In Drug Discovery And Diagnostics Market?

Major companies operating in the deep learning in drug discovery and diagnostics market are Google Inc., Microsoft Corporation, International Business Machines Corporation, NVIDIA Corporation, Zebra Medical Vision Ltd, Tempus Labs Inc., Nanostring Technologies Inc., Owkin Inc., Insilico Medicine Inc., SOPHiA GENETICS SA, Qureai Technologies Pvt Ltd, H2Oai Inc., Arterys Inc., Deep Genomics Inc., GNS Healthcare Inc., MedAware Systems Inc., PathAI Inc., Kheiron Medical Technologies Ltd, CureMetrix Inc., OncoImmunity AS, Proscia Inc., BenevolentAI Ltd, BioXcel Therapeutics Inc.

Read the full deep learning in drug discovery and diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/deep-learning-in-drug-discovery-and-diagnostics-global-market-report

Which Geographic Regions Are Influencing Demand In The Deep Learning In Drug Discovery And Diagnostics Market?

North America was the largest region in the deep learning in drug discovery and diagnostics market in 2025. The regions covered in the deep learning in drug discovery and diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Deep Learning In Drug Discovery And Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19394&type=smp

Browse Through More Reports Similar to the Global Deep Learning In Drug Discovery And Diagnostics Market 2026, By The Business Research Company

Artificial Intelligence In Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

Ai In Medical Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Artificial Intelligence In Healthcare Diagnosis Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795